Cancer survivors face a 14% higher risk of developing entirely new cancers (secondary malignancies) compared to the general population, and they account for nearly 19% of all cancer diagnoses in the U.S. Oncology Advanced Practice Providers (APPs) highlight that past treatments, especially radiation and certain chemotherapies like alkylating agents, platinum-based drugs, anthracycline topoisomerase II inhibitors, and even targeted therapies, can contribute to long-term risk.
Archives: News
News stories
Survivors of Childhood Cancer May Face Higher Risk from Severe COVID-19
New research from a large study in Denmark and Sweden, shows that adult survivors of childhood cancer, including those treated for Hodgkin lymphoma, may be at greater risk for severe illness from COVID-19. This increased vulnerability is likely linked to lasting effects from cancer treatments, such as weakened immune systems or damage to organs like the lungs and heart.
Weighing First-Line Treatment Options for Advanced-Stage Hodgkin Lymphoma
For people newly diagnosed with advanced-stage classical Hodgkin lymphoma, choosing a first-line treatment can feel overwhelming. This article reviews the most widely used treatments, outlining how they compare in terms of both effectiveness and long-term side effects. The goal is not just remission but also protecting the quality of life for years to come.
Preparing Survivors for the Risk of Secondary Cancers
Many long-term Hodgkin lymphoma survivors face an increased risk of developing secondary cancers, often as a result of earlier treatments like chemotherapy or radiation. These risks can emerge years or even decades after treatment, making ongoing awareness and screening a critical part of survivorship care.
A Roundtable on the Current State of U.S. Cancer Research
WNYC’s Brian Lehrer Show featured an insightful panel discussion on the current landscape of cancer research in the United States.
University of Cincinnati Provides Primary Care for Adolescent and Young Adult Cancer Survivors
The University of Cincinnati has launched one of the first oncology-focused primary care clinics specifically for Adolescent and Young Adult (AYA) cancer survivors, those diagnosed between the ages 18 and 39. This new model addresses the complex, long-term health risks survivors face, including second cancers, heart disease, and emotional challenges, by combining oncology knowledge with general preventive care. Early data shows high rates of chronic conditions and a strong need for coordinated, survivor-centered care.
Can Chemo and Other Cancer Treatments Cause Heart Problems?
A collaboration between ASCO and the American Cancer Society confirms that the answer is YES. Treatments like anthracyclines, chest radiation, immunotherapy, and targeted therapy can place significant stress on the heart, increasing the risk of long-term issues such as high blood pressure, irregular heartbeat, or even heart failure.
Who Will Care for Cancer Survivors?
A promising approach featured in the article is survivorship-focused primary care, where physicians trained in both oncology and internal medicine provide ongoing, comprehensive care. Early results show this model improves screening, identifies late effects sooner, and enhances quality of life. For Hodgkin lymphoma survivors, who often face serious late effects years or decades after treatment, this kind of care could be life‑saving.
Finding Inspiration After Cancer: Practical Tips for Reigniting Your Spark
In this article, Dr. Gary McClain offers strategies to help cancer survivors rediscover inspiration in their lives. Acknowledging that the journey through cancer can be overwhelming, Dr. McClain emphasizes that inspiration is attainable through intentional actions. He suggests practices such as spending quiet time alone to reflect, engaging with uplifting music, decluttering both physical and mental spaces, seeking out role models, and sharing personal stories to inspire others. These steps can assist survivors in reconnecting with their inner drive and finding renewed purpose.
7th Heaven Alum and Hodgkin Lymphoma Survivor Barry Watson
Actor Barry Watson shares his journey from a Hodgkin lymphoma diagnosis to over a decade of survivorship. His story highlights the importance of a positive attitude and the support of others during treatment and recovery.